µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Duchenne Muscular Dystrophy Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»óǰÄÚµå : 1612852
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 170 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÁÖ¿ä ÀλçÀÌÆ®

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

À¯Àü ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, »ý¸í°øÇÐ ±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀÎÀÌ ¼¼°è DMD Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. À¯ÀüÀÚ Ä¡·á ¹× ¿¢¼Õ ½ºÅ°ÇÎ Ä¡·á¿Í °°Àº Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÇ °³¹ßÀº DMD Ä¡·á¿¡ Çõ¸íÀ» ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. Èñ±ÍÁúȯ ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡¿Í Á¦¾àȸ»ç¿Í Çмú±â°üÀÇ Çù·Âµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ Áö¿ø ´Üü´Â ÀÎÁöµµ¸¦ ³ôÀ̰í ÀǾàǰ °³¹ß ÀÌ´Ï¼ÅÆ¼ºê¸¦ Áö¿øÇÏ´Â µ¥ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¾ïÁ¦¿äÀÎ:

DMD Ä¡·á ½ÃÀåÀº Å« ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖÁö¸¸, ³ôÀº Ä¡·áºñ, Àú¼Òµæ Áö¿ª¿¡¼­ÀÇ Ã·´Ü Ä¡·á Á¢±Ù¼º Á¦ÇÑ, Èñ±Í À¯Àü¼º Áúȯ Ä¡·áÁ¦ °³¹ßÀÇ º¹À⼺ µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ±ÔÁ¦ À庮°ú ±ä ÀÓ»ó½ÃÇè ±â°£µµ ½ÃÀå ¼ºÀå¿¡ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±Ùº»ÀûÀÎ Ä¡·á¹ýÀÇ ºÎÀç¿Í ±âÁ¸ Ä¡·áÁ¦ÀÇ ÀáÀçÀû ºÎÀÛ¿ëµµ º¸±Þ¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

DMD Ä¡·á ½ÃÀåÀº ƯÈ÷ ½ÅÈï °æÁ¦±¹¿¡¼­ À¯ÀüÀÚ ±â¹Ý Ä¡·áÀÇ Ã¤Åà Ȯ´ë°¡ Å« ¼ºÀå ±âȸ·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÂÃãÇü Ä¡·á¿Í Ç¥ÀûÄ¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ »õ·Î¿î ¼ºÀå ±âȸ·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾àȸ»ç¿Í R&D ±â°ü°úÀÇ Á¦ÈÞ¸¦ ÅëÇØ »õ·Î¿î Ä¡·áÁ¦ °³¹ßÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå ÁøÃâ°ú Áø´Ü ±â¼úÀÇ ¹ßÀüÀº ½ÃÀå Àü¸ÁÀ» ´õ¿í ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀÇ µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ Á¤ÀÇ¿Í °³¿ä, ½ÃÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, °¢Á¾ µ¿Çâ, ½ÃÀå ±âȸ¿Í °úÁ¦, ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ÀϺΠ¼ö·®) ÃßÀÌ¿Í ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù. ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°è °æÁ¦ Àü¸Á

Á¦2Àå µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ¼¼°è ½ÃÀå : ÁÖ¿ä ¿ä¾à

Á¦3Àå µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ¼¼°è ½ÃÀå : °³¿ä

Á¦4Àå µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ¼¼°è ½ÃÀå : ºÐ¼®°ú ¿¹Ãø

Á¦5Àå ºÏ¹ÌÀÇ µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø

Á¦6Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø

Á¦7Àå À¯·´ÀÇ µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø

Á¦8Àå ÀϺ»ÀÇ µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø

Á¦9Àå ÀϺ»À» Á¦¿ÜÇÑ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø

Á¦11Àå ¼¼°èÀÇ µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) Ä¡·á ½ÃÀå : ±â¾÷ Á¡À¯À², °æÀï ±¸µµ, ±â¾÷ °³¿ä

Á¦12Àå Á¶»ç ¹æ¹ý

Á¦13Àå ¸éÃ¥»çÇ×

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the global Duchenne Muscular Dystrophy Treatment Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Duchenne Muscular Dystrophy Treatment Market - Report Scope:

The global Duchenne Muscular Dystrophy (DMD) treatment market includes a variety of therapeutic options, ranging from corticosteroids to exon-skipping therapies and gene-based treatments. The market growth is largely driven by advancements in genetic therapies, increased investments in research and development, and rising awareness about muscular dystrophy. The demand for effective treatments is further bolstered by regulatory support, growing healthcare expenditures, and increasing patient access to innovative therapeutic options.

Market Growth Drivers:

Several factors are driving the growth of the global DMD treatment market, including an increase in the prevalence of genetic disorders, growing awareness about early diagnosis, and advancements in biotechnology. The development of innovative treatments, such as gene therapy and exon-skipping therapies, is revolutionizing the management of DMD. Increased funding for rare disease research and collaborations between pharmaceutical companies and academic institutions also contribute to market expansion. Furthermore, patient advocacy groups play a crucial role in promoting awareness and supporting drug development initiatives.

Market Restraints:

Despite strong growth potential, the DMD treatment market faces challenges, including high treatment costs, limited access to advanced therapies in low-income regions, and the complexity of drug development for rare genetic disorders. Regulatory hurdles and the long duration of clinical trials also pose significant barriers to market growth. Moreover, the lack of curative treatments and potential side effects of existing therapies may hinder widespread adoption.

Market Opportunities:

The DMD treatment market offers significant growth opportunities driven by the increasing adoption of gene-based therapies, particularly in developed economies. The rise in demand for personalized medicine and targeted therapies presents another opportunity. Additionally, partnerships between pharmaceutical companies and research organizations are accelerating the development of novel treatments. Expansion into emerging markets and advancements in diagnostic technologies can further enhance market prospects.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading companies in the global Duchenne Muscular Dystrophy treatment market, such as Sarepta Therapeutics, Pfizer Inc., and PTC Therapeutics, are focusing on product innovation, strategic collaborations, and clinical trial advancements to maintain a competitive edge. These companies are investing in gene-editing technologies, such as CRISPR, and developing advanced exon-skipping drugs. Collaborations with research institutions and patient advocacy groups enhance market reach and foster trust. Additionally, focusing on affordability and expanding access to treatments in underserved regions helps companies cater to the growing demand for effective DMD therapies.

Key Companies Profiled:

Duchenne Muscular Dystrophy Treatment Industry Research by Category:

By Product Type

By Distribution Channel

By Therapy

By Region

Table of Contents

1. Global Economic Outlook

2. Global Duchenne Muscular Dystrophy Market - Executive Summary

3. Global Duchenne Muscular Dystrophy Market Overview

4. Global Duchenne Muscular Dystrophy Market Analysis and Forecast 2024 - 2031

5. North America Duchenne Muscular Dystrophy Market Size and Forecast, 2024 - 2031

6. Latin America Duchenne Muscular Dystrophy Market Size and Forecast, 2024 - 2031

7. Europe Duchenne Muscular Dystrophy Market Size and Forecast, 2024 - 2031

8. Japan Duchenne Muscular Dystrophy Market Size and Forecast, 2024 - 2031

9. APEJ Duchenne Muscular Dystrophy Market Size and Forecast, 2024 - 2031

10. MEA Duchenne Muscular Dystrophy Market Size and Forecast, 2024 - 2031

11. Global Duchenne Muscular Dystrophy Market Company Share, Competition Landscape and Company Profiles

12. Research Methodology

13. Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â